BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2316912)

  • 1. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing.
    Williams RJ; Boudinot FD; Smith JA; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):371-5. PubMed ID: 2316912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls.
    Williams RJ; Smith JA; Boudinot FD; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):367-70. PubMed ID: 2316911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of phenylbutazone in neonatal foals.
    Wilcke JR; Crisman MV; Sams RA; Gerken DF
    Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
    Brown SA; Cooper J; Gauze JJ; Greco DS; Weise DW; Buck JM
    Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse.
    Foreman JH; Barange A; Lawrence LM; Hungerford LL
    J Vet Pharmacol Ther; 2008 Feb; 31(1):39-44. PubMed ID: 18177317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
    Arifah AK; Lees P
    J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
    Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin.
    Jayachandra Babu R; Ravis WR; Duran SH; Schumacher J; Cox E; Stahl R; Jones K; Jean Lin YJ; Phillip Lee YH; Parsons DL; Portman EM; Brown SC
    J Vet Pharmacol Ther; 2009 Aug; 32(4):388-92. PubMed ID: 19614844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
    Foreman JH; Ruemmler R
    Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of flunixin meglumine in lactating cattle after single and multiple intramuscular and intravenous administrations.
    Anderson KL; Neff-Davis CA; Davis LE; Bass VD
    Am J Vet Res; 1990 Sep; 51(9):1464-7. PubMed ID: 2396794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and effects of repeated administration of phenylbutazone in neonatal calves.
    Semrad SD; McClure JT; Sams RA; Kaminski LM
    Am J Vet Res; 1993 Nov; 54(11):1906-12. PubMed ID: 8291771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of L-thyroxine after its oral administration in dogs.
    Nachreiner RF; Refsal KR; Ravis WR; Hauptman J; Rosser EJ; Pedersoli WM
    Am J Vet Res; 1993 Dec; 54(12):2091-8. PubMed ID: 8116944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration.
    Mills PC; Ng JC; Skelton KV; Seawright AA; Auer DE
    Aust Vet J; 1995 Aug; 72(8):304-8. PubMed ID: 8579562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
    Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
    Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.